Changes in the Medicare Audit Landscape as of 2026: Increasing Extrapolation, and What This Means for Providers

April 2026
By: Shaniya Raheja, Wachler & Associates, P.C

Background

Over the past year, Medicare providers have increasingly felt the harsh effects of a shifting federal enforcement landscape. CMS has adopted a more assertive program‑integrity posture across all of its operations, signaling a renewed focus on payment accuracy and fraud‑prevention initiatives. This broader regulatory trend is reflected in the 2025 Marketplace Integrity and Affordability Final Rule, where CMS emphasized its intent to “strengthen program integrity standards,” “promote accurate eligibility determinations,” and “improve oversight and reduce vulnerabilities to fraud and abuse” across federally administered programs (CMS Marketplace Integrity and Affordability Final Rule Fact Sheet, 2025). Although the rule governs marketplace operations, it reflects the same enforcement philosophy now driving Medicare’s expanded audit activity in 2026. This context is essential to understanding why Medicare contractors have intensified their oversight efforts and why providers are experiencing a measurable increase in Medicare audits, particularly with respect to the growing reliance on statistical extrapolation.

Growing Reliance on Extrapolation in 2026 Audit Activity

One of the most consequential developments driving this increase in audit activity is the expanded use of statistical extrapolation in Medicare overpayment determinations. CMS revised the Program Integrity Manual in 2025 to expressly encourage contractors to apply extrapolation whenever data analysis suggests a “high level of payment error” or a pattern of improper billing, and to rely on statistical sampling even in relatively small probe reviews (CMS, Program Integrity Manual, Ch. 8, § 8.4.1.2, rev. 2025). In practice, UPICs, MACs, and Medicare Advantage SIUs are now extrapolating alleged overpayments from samples as small as twenty to forty claims and projecting those findings across a much larger universe of services. This shift has produced substantial overpayment demands based on limited documentation findings—often involving technical deficiencies rather than substantive medical‑necessity failures, a trend that has materially increased the financial stakes of even routine post‑payment reviews.

OIG has likewise reaffirmed that statistical sampling is a “valid and widely accepted methodology” for estimating overpayments and has encouraged contractors to use extrapolation when significant billing errors are identified (OIG, Medicare Contractors’ Use of Statistical Sampling and Extrapolation, 2025). CMS has echoed this position in its appeals guidance, noting that extrapolation is appropriate whenever there is reason to believe that billing errors extend beyond the claims actually reviewed (CMS, Statistical Sampling & Extrapolation Guidance, 2025). As extrapolation becomes more prevalent in 2026, providers must understand not only the clinical and documentation issues underlying an audit, but also the statistical methodology used to calculate the alleged overpayment—an area that is increasingly central to successful audit defense and one that CMS contractors are now leveraging far more aggressively than in prior years.

Provider Exposure and the Importance of Methodological Challenges

The implications of this expanded use of extrapolation are significant for providers. Because extrapolation allows contractors to project alleged errors across an entire universe of claims, even minor documentation deficiencies can result in six‑ or seven‑figure overpayment demands. This is particularly problematic where the underlying denials stem from technical issues—such as incomplete time documentation, missing signatures, or insufficient wound‑care measurements—rather than true questions of medical necessity. In this environment, providers face heightened financial exposure and must be prepared for the possibility that a small sample of claims may be used to justify a substantial repayment obligation. The increased reliance on extrapolation also accelerates the timeline in which providers must respond, as contractors often proceed directly to recoupment once an extrapolated overpayment is issued, leaving providers with limited time to mount a statistically grounded defense.

These developments place a premium on proactive compliance. Providers must ensure that documentation is complete, consistent, and defensible across all claims—not merely those selected for audit—because any identified deficiency may be magnified through extrapolation. Equally important, providers must understand their appeal rights, including the ability to challenge the statistical validity of the sample and methodology used to calculate the extrapolated amount. CMS and OIG guidance make clear that extrapolation is permissible only when the sampling design is statistically valid and properly executed (CMS, Statistical Sampling & Extrapolation Guidance, 2025; OIG, Medicare Contractors’ Use of Statistical Sampling and Extrapolation, 2025). Providers who engage early, scrutinize the sampling methodology, and raise procedural challenges alongside clinical arguments are far better positioned to mitigate the financial and operational impact of these audits, particularly as contractors increasingly rely on complex statistical models that may not withstand rigorous methodological scrutiny.

Conclusion

As Medicare audit activity continues to intensify in 2026, statistical extrapolation has emerged as the defining feature of the current enforcement landscape. What was once a tool reserved for large‑scale fraud investigations is now routinely applied in standard post‑payment reviews, dramatically amplifying the financial consequences of even minor documentation lapses. For providers, the path forward requires a dual focus: strengthening day‑to‑day documentation practices to minimize exposure and developing a sophisticated understanding of the statistical principles that govern extrapolation. By recognizing that extrapolation is now central—not peripheral—to Medicare audit strategy, providers can better anticipate audit risk, assert their appeal rights effectively, and position themselves to navigate an increasingly data‑driven enforcement environment.